News

DCGI Tightens Crackdown on Unauthorised Sale of GLP-1 Weight Loss Drugs Across India

March 26, 2026 2 min read
author Our Correspondent,
The Drugs Controller of India (DCGI) has stepped up its regulatory oversight to curb the unauthorised sale and promotion of GLP-1 weight loss drugs, aiming to ensure ethical practices across the pharmaceutical supply chain. The growing availability of newly introduced generic variants of GLP-1-based weight loss drugs in the Indian market has triggered concerns, particularly as these medications are increasingly accessible through

The only supply chain registration you need

Unrivaled context behind every news and article for free.

Register
logo

Subscribe to Our Newsletter

The week’s best stories, handpicked by JOSC editors in your inbox every week.

Stay informed with exclusive content